Registry for autoimmune and cholestatic liver diseases in Spain

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to gather comprehensive data on patients diagnosed with primary biliary cholangitis, autoimmune hepatitis, primary sclerosing cholangitis, and genetic cholestatic diseases in Spain. By collecting and analyzing patient information, the registry seeks to enhance understanding of these conditions and improve patient care. The observational nature of the study allows for real-world data collection without any specific interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with a confirmed diagnosis for PBC, HAI, PSC, genetic cholestatic disease

Exclusion Criteria:

* Refusal to sign the informed consent for the study

Where it's running

• Hospital Clinic
  Barcelona, Spain Recruiting

Study contacts

• Study coordinator: Asociación Española para el Estudio del Hígado Asociación Espa
• Email: registrocolhay@gmail.com
• Phone: 0034915551119

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biodegradable stents for high-grade bile duct strictures in PSC

  This study tests whether placing biodegradable stents helps open tight bile duct strictures in people with primary sclerosing cholangitis.

  Recruiting King's College Hospital NHS Trust · London · NCT07607353

• Biochemical response and health outcomes in people with primary biliary cholangitis

  We will follow adults with primary biliary cholangitis who are taking ursodeoxycholic acid (UDCA) to see if their alkaline phosphatase levels after treatment predict how long they stay free of complications.

  Recruiting RenJi Hospital · Shanghai, Shanghai Municipality · NCT07449793

• Vancomycin for active ulcerative colitis with primary sclerosing cholangitis

  This study tests whether oral vancomycin can help adults with both ulcerative colitis and primary sclerosing cholangitis more than a placebo over four weeks.

  Recruiting Phase 2 McMaster University · Hamilton, Ontario · NCT07341282

• Fenofibrate versus UDCA for first-line treatment of primary biliary cholangitis

  This study will test whether fenofibrate works better than the standard medicine UDCA for adults with newly diagnosed primary biliary cholangitis who have not been treated before.

  Recruiting at 2 sites Phase 3 Xijing Hospital of Digestive Diseases · Guangzhou, Guangdong and 1 other locations · NCT07296458

• Early detection of primary biliary cholangitis in people with positive AMA and normal ALP

  This project will test whether clinical features, blood markers, or a liver biopsy can identify early PBC in adults (18-80) who have positive AMA but normal ALP.

  Recruiting Hospital Universitario La Paz · Madrid · NCT07205874

• Multimodal prehabilitation to reduce fatigue in primary biliary cholangitis

  This trial will try a combined program of supervised exercise, nutritional counseling, and mindfulness to reduce fatigue in adults with primary biliary cholangitis who have moderate-to-severe fatigue.

  Recruiting Hospital Clinic of Barcelona · Barcelona, Barcelona · NCT07161245

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.